Jeffrey S. Hatfield - 30 May 2024 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
Issuer symbol
VIR
Transactions as of
30 May 2024
Net transactions value
$0
Form type
4
Filing time
03 Jun 2024, 11:59:32 UTC
Previous filing
24 May 2023
Next filing
02 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +8,000 +51% $0.000000 23,806 30 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 30 May 2024 Common Stock 16,000 $10.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.